The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,110
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Self-citationEfficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Breedveld, F. C., Weisman, M. H., Kavanaugh, A. F., Cohen, S. B., Pavelka, K., Vollenhoven, R. V., Sharp, J., Perez, J. L., & Spencer‐Green, G. T. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21519 · Cited by 1,785
Weinblatt, M. E., Keystone, E. C., Furst, D. E., Moreland, L. W., Weisman, M. H., Birbara, C. A., Teoh, L. A., Fischkoff, S. A., & Chartash, E. K. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10697 · Cited by 1,757
Self-citationKlareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15640-7 · Cited by 1,751
Cohen, S. B., Emery, P., Greenwald, M. W., Dougados, M., Furie, R. A., Genovese, M. C., Keystone, E. C., Loveless, J. E., Burmester, G., Cravets, M. W., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22025 · Cited by 1,638
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
Genovese, M. C., Becker, J.-C., Schiff, M., Luggen, M., Sherrer, Y., Kremer, J., Birbara, C., Box, J., Natarajan, K., Nuamah, I., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050524 · Cited by 1,241
Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M., & Gabriel, S. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10524 · Cited by 1,214
Keystone, E. C., Kavanaugh, A. F., Sharp, J. T., Tannenbaum, H., Hua, Y., Teoh, L. S., Fischkoff, S. A., & Chartash, E. K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20217 · Cited by 1,172
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., Paulus, H. E., Mudano, A., Pisu, M., Elkins‐Melton, M., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23721 · Cited by 1,157
Self-citationINFLIXIMAB AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS
Ipsky, P. E. E. L., Illiam, E. W., Urst, D. A. E. F., Reedveld, C. B., Oachim, J., Alden, R. K., Osef, J., Molen, S. S., Eisman, M. I. W., Mery, P. A. E., et al. (2000) · Cited by 1,155
St. Clair, E. W., van der Heijde, D. M. F. M., Smolen, J. S., Maini, R. N., Bathon, J. M., Emery, P., Keystone, E., Schiff, M., Kalden, J. R., Wang, B., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20568 · Cited by 1,143
Emery, P., Fleischmann, R., Filipowicz‐Sosnowska, A., Schechtman, J., Szczepanski, L., Kavanaugh, A., Racewicz, A. J., van Vollenhoven, R. F., Li, N. F., Agarwal, S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21778 · Cited by 1,060
Kremer, J. M., Westhovens, R., Leon, M., Di Giorgio, E., Alten, R., Steinfeld, S., Russell, A., Dougados, M., Emery, P., Nuamah, I. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035075 · Cited by 1,058
Gómez‐Reino, J. J., Carmona, L., Valverde, V. R., Mola, E. M., & Montero, M. D. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11137 · Cited by 1,013
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Bresnihan, B., Alvaro-Gracia, J. M., Cobby, M., Doherty, M., Domljan, Z., Emery, P., Nuki, G., Pavelka, K., Rau, R., Rozman, B., et al. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199812)41:12<2196::aid-art15>3.0.co;2-2 · Cited by 981
Dixon, W. G., Watson, K., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21978 · Cited by 751
Genovese, M. C., Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10308 · Cited by 733
Kremer, J. M., Genant, H. K., Moreland, L. W., Russell, A. S., Emery, P., Abud-Mendoza, C., Szechinski, J., Li, T., Ge, Z., Becker, J.-C., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-12-200606200-00003 · Cited by 715
Tumour necrosis factors α and β inhibit virus replication and synergize with interferons
Wong, G. H. W., & Goeddel, D. V. (1986) · Nature · doi:10.1038/323819a0 · Cited by 713
Infections in patients with rheumatoid arthritis treated with biologic agents
Listing, J., Strangfeld, A., Kary, S., Rau, R., von Hinueber, U., Stoyanova‐Scholz, M., Gromnica‐Ihle, E., Antoni, C., Herzer, P., Kekow, J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21386 · Cited by 681
Carmona, L., Gómez‐Reino, J. J., Rodríguez‐Valverde, V., Montero, D., Pascual‐Gómez, E., Mola, E. M., Carreño, L., Figueroa, M., & BIOBADASER Group (2005) · Arthritis & Rheumatism · doi:10.1002/art.21043 · Cited by 656
Cohen, S., Hurd, E., Cush, J., Schiff, M., Weinblatt, M. E., Moreland, L. W., Kremer, J., Bear, M. B., Rich, W. J., & McCabe, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10141 · Cited by 638
van de Putte, L. B. A., Atkins, C., Malaise, M., Sany, J., Russell, A. S., van Riel, P. L. C. M., Settas, L., Bijlsma, J. W., Todesco, S., Dougados, M., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.013052 · Cited by 617
Schiff, M., Keiserman, M., Codding, C., Songcharoen, S., Berman, A., Nayiager, S., Saldate, C., Li, T., Aranda, R., Becker, J.-C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080002 · Cited by 539
Maini, R. N., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Furst, D., Weisman, M. H., St.Clair, E. W., Keenan, G. F., van der Heijde, D., Marsters, P. A., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20159 · Cited by 514
Self-citationFurst, D. E., Schiff, M. H., Fleischmann, R., Strand, V., Birbara, C. A., Compagnone, D., Fischkoff, S. A., & Chartash, E. (2003) · PubMed · Cited by 495
Self-citationTolerability and safety of rituximab (MabThera®)
Kimby, E. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.05.007 · Cited by 470
Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy
Wolfe, F., Michaud, K., Anderson, J., & Urbansky, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20009 · Cited by 431
Askling, J., Fored, C. M., Brandt, L., Baecklund, E., Bertilsson, L., Cöster, L., Geborek, P., Jacobsson, L. T., Lindblad, S., Lysholm, J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21137 · Cited by 419
Curtis, J. R., Patkar, N., Xie, A., Martin, C., Allison, J. J., Saag, M., Shatin, D., & Saag, K. G. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22504 · Cited by 398
Fleischmann, R. M., Schechtman, J., Bennett, R., Handel, M. L., Burmester, G., Tesser, J., Modafferi, D., Poulakos, J., & Sun, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10870 · Cited by 392
Schiff, M. H., Burmester, G. R., Kent, J. D., Pangan, A. L., Kupper, H., Fitzpatrick, S. B., & Donovan, C. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.043166 · Cited by 390
Weinblatt, M., Combe, B., Covucci, A., Aranda, R., Becker, J. C., & Keystone, E. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22070 · Cited by 386
The Immune System in Health and Disease
Janeway, C. A., Travers, P. J., Walport, M. J., & Shlomchik, M. J. (2001) · Cited by 374
Length of Life and Cause of Death in Rheumatoid Arthritis
Cobb, S., Anderson, F., & Bauer, W. (1953) · New England Journal of Medicine · doi:10.1056/nejm195310012491402 · Cited by 362
Keystone, E., Fleischmann, R., Emery, P., Furst, D. E., van Vollenhoven, R., Bathon, J., Dougados, M., Baldassare, A., Ferraccioli, G., Chubick, A., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23059 · Cited by 337
Self-citationAskling, J., Fored, C. M., Brandt, L., Baecklund, E., Bertilsson, L., Feltelius, N., Cöster, L., Geborek, P., Jacobsson, L. T., Lindblad, S., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062760 · Cited by 334
Ledingham, J., Deighton, C., & on behalf of the British Society for Rheumatology Standards, G. A. A. W. G. (2005) · Rheumatology · doi:10.1093/rheumatology/keh464 · Cited by 331
Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy
Kroesen, S. (2003) · Rheumatology · doi:10.1093/rheumatology/keg263 · Cited by 328
Kapetanovic, M. C., Saxne, T., Sjöholm, A., Truedsson, L., Jönsson, G., & Geborek, P. (2006) · Rheumatology · doi:10.1093/rheumatology/kei193 · Cited by 319
Dixon, W. G., Symmons, D. P. M., Lunt, M., Watson, K. D., Hyrich, K. L., & Silman, A. J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22808 · Cited by 307
Cohen, S. B., Moreland, L. W., Cush, J. J., Greenwald, M. W., Block, S., Shergy, W. J., Hanrahan, P. S., Kraishi, M. M., Patel, A., Sun, G., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016014 · Cited by 305
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
Fleischmann, R. M., Tesser, J., Schiff, M. H., Schechtman, J., Burmester, G.-R., Bennett, R., Modafferi, D., Zhou, L., Bell, D., & Appleton, B. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.048371 · Cited by 305
Weinblatt, M., Schiff, M., Goldman, A., Kremer, J., Luggen, M., Li, T., Chen, D., & Becker, J.-C. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055111 · Cited by 300
Infections and anti–tumor necrosis factor α therapy
Ellerin, T., Rubin, R. H., & Weinblatt, M. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11301 · Cited by 284
den Broeder, A. A., Creemers, M. C. W., Fransen, J., et al. (2007) · PubMed · Cited by 280
Giles, J. T., Bartlett, S. J., Gelber, A. C., Nanda, S., Fontaine, K. R., Ruffing, V., & Bathon, J. M. (2006) · Arthritis Care & Research · doi:10.1002/art.21841 · Cited by 267
Fomin, I., Caspi, D., Levy, V, Varsano, N., Shalev, Y., Paran, D., Levartovsky, D., Litinsky, I., Kaufman, I., Wigler, I., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.036434 · Cited by 267
Zein, N. N., & for the Etanercept Study Group (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.025 · Cited by 248
Kaine, J., Kivitz, A., Birbara, C. A., & Luo, A. Y. (2007) · PubMed · Cited by 246
Oren, S., Mandelboim, M., Braun-Moscovici, Y., Paran, D., Ablin, J., Litinsky, I., Comaneshter, D., Levartovsky, D., Mendelson, E., Azar, R., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.077461 · Cited by 241
Increased risk of tuberculosis in patients with rheumatoid arthritis.
Carmona, L., Hernández‐García, C., Vadillo, C., Pato, E., Balsa, A., González‐Álvaro, I., Belmonte, M. Á., Tena, X., & Sanmartí, R. (2003) · PubMed · Cited by 233
Infliximab: A Review of its Use in the Management of Rheumatoid Arthritis
Markham, A., & Lamb, H. M. (2000) · Drugs · doi:10.2165/00003495-200059060-00010 · Cited by 227
Bibbo, C., & Goldberg, J. W. (2004) · Foot & Ankle International · doi:10.1177/107110070402500510 · Cited by 217
Ostuni, P., Botsios, C., Punzi, L., Sfriso, P., & Todesco, S. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.7.686 · Cited by 217
Peterson, J. R., Hsu, F. C., Simkin, P. A., & Wener, M. H. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1078 · Cited by 208
Reactivation of Latent Granulomatous Infections by Infliximab
Wallis, R. S., Broder, M., Wong, J., Lee, A., & Hoq, L. (2005) · Clinical Infectious Diseases · doi:10.1086/429996 · Cited by 191
Kapetanovic, M. C., Saxne, T., Nilsson, J.-A., & Geborek, P. (2006) · Rheumatology · doi:10.1093/rheumatology/kel366 · Cited by 191
喬, 嶋. (1992) · doi:10.11381/jjcdp1974.26.198 · Cited by 187
Is IL-1 a good therapeutic target in the treatment of arthritis?
Burger, D., Dayer, J.-M., Palmer, G., & Gabay, C. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.06.004 · Cited by 175
van Riel, P. L. C. M., Taggart, A. J., Sany, J., Gaubitz, M., Nab, H. W., Pedersen, R., Freundlich, B., & MacPeek, D. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.043299 · Cited by 136
van der Veen, M. J., van der Heide, A., Kruize, A. A., & Bijlsma, J. W. J. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.4.224 · Cited by 131
Visvanathan, S., Keenan, G. F., Baker, D. G., Levinson, A. I., & Wagner, C. L. (2007) · PubMed · Cited by 130
Co-morbidity in rheumatoid arthritis
Mikuls, T. R. (2003) · Best Practice & Research Clinical Rheumatology · doi:10.1016/s1521-6942(03)00041-x · Cited by 122
Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis
Fleischmann, R., Stern, R., & Iqbal, I. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.8.1333 · Cited by 106
Ruderman, E., & Pope, R. M. (2005) · Arthritis Research · doi:10.1186/ar1688 · Cited by 101
Rosa, F. G. D., Shaz, D. J., Campagna, A. C., Dellaripa, P. F., Khettry, U., & Craven, D. E. (2003) · Infection Control and Hospital Epidemiology · doi:10.1086/502250 · Cited by 96
Etanercept in rheumatoid arthritis
Alldred, A. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.7.1137 · Cited by 83
Haerter, G., Manfras, B. J., de Jong‐Hesse, Y., Wilts, H., Mertens, T., Kern, P., & Schmitt, M. (2004) · Clinical Infectious Diseases · doi:10.1086/425123 · Cited by 81
Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice
Bigbee, C., Gonchoroff, D. G., Vratsanos, G., Nadler, S. G., Haggerty, H. G., & Flynn, J. L. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22750 · Cited by 77
Listeria Meningitis Associated with Infliximab
Bowie, V. L., Snella, K. A., Gopalachar, A. S., & Bharadwaj, P. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d151 · Cited by 67
Cruyssen, B. V., Looy, S. V., Wyns, B., Westhovens, R., Durez, P., den Bosch, F. E. V., Mielants, H., Clerck, L. S. D., Peretz, A., Malaise, M., et al. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2001 · Cited by 55
Mufti, A., Toye, B. W., Mckendry, R. R. J., et al. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.06.006 · Cited by 55
Beltrán, B., Nos, P., Bastida, G., Iborra, M., Hoyos, M., & Ponce, J. (2006) · Gut · doi:10.1136/gut.2006.101386 · Cited by 55
Elwood, R. L., Pelszynski, M., & Corman, L. I. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000055092.90609.e5 · Cited by 50
Adalimumab ? a new TNF-alpha antibody for treatment of inflammatory joint disease
Machold, K. P., & Smolen, J. S. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.2.351 · Cited by 48
Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
Yamamoto, M., Takahashi, H., Wakasugi, H., Sukawa, Y., Saito, M., Suzuki, C., Naishiro, Y., Yamamoto, H., Shinomura, Y., & Imai, K. (2007) · Modern Rheumatology · doi:10.1007/s10165-006-0530-2 · Cited by 45
Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis
Dass, S., Vital, E. M. J., & Emery, P. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.18.2559 · Cited by 42
Sipsas, N. V., Papaparaskevas, J., Stefanou, I., Kalatzis, K., Vlachoyiannopoulos, P. G., & Avlamis, A. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.01.028 · Cited by 39
Recurrent Mycobacterium xenopi infection in a patient with rheumatoid arthritis receiving etanercept
Yim, K., Nazeer, S. H., Kiska, D. L., Rose, F. B., Brown, D., & Cynamon, M. H. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310017474 · Cited by 38
Mycobacteria tuberculosis peritonitis associated with etanercept therapy.
Manadan, A. M., Block, J. A., & Sequeira, W. (2004) · PubMed · Cited by 34
A case of Legionellosis during treatment with a TNFα antagonist
Wondergem, M. J., Voskuyl, A. E., & van Agtmael, M. A. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410019598 · Cited by 33
Does etanercept monotherapy enhance the risk of Listeria monocytogenes meningitis?
Pagliano, P., Attanasio, V., Fusco, U., Mohamed, D. A., Rossi, M., & Faella, F. S. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.015966 · Cited by 32
Efdé, M., Houtman, P. M., Spoorenberg, J. P. L., & Jansen, T. (2005) · PubMed · Cited by 31
Tuberculous peritonitis in a patient with rheumatoid arthritis treated with adalimumab
Macías, A. G., Palacios, E. L., Martínez-Odriozola, P., & la Villa, F. M.-D. (2006) · Clinical Rheumatology · doi:10.1007/s10067-005-0164-3 · Cited by 26
Gerster, J. C., & Dudler, J. (2004) · Clinical Rheumatology · doi:10.1007/s10067-004-0950-3 · Cited by 22
Cabou, C., Bagheri, H., Cantagrel, A. G., Mazières, B., & Montastruc, J. (2003) · Therapies · doi:10.2515/therapie:2003074 · Cited by 11
Cited by
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Self-citationClinical targeting of the TNF and TNFR superfamilies
Croft, M., Benedict, C. A., & Ware, C. F. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3930 · Cited by 456
Grijalva, C. G., Chen, L., Delzell, E., Baddley, J. W., Beukelman, T., Winthrop, K. L., Griffin, M. R., Herrinton, L. J., Liu, L., Ouellet-Hellstrom, R., et al. (2011) · JAMA · doi:10.1001/jama.2011.1692 · Cited by 350
Genovese, M. C., Durez, P., Richards, H. B., Supronik, J., Dokoupilova, E., Mazurov, V., Aelion, J. A., Lee, S.-H., Codding, C. E., Kellner, H., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201601 · Cited by 293
Deodhar, A., Mease, P. J., McInnes, I. B., Baraliakos, X., Reich, K., Blauvelt, A., Leonardi, C., Porter, B., Das Gupta, A., Widmer, A., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1882-2 · Cited by 292
Metadata
- Authors
- Furst, D. E.
- Venue
- Seminars in Arthritis and Rheumatism
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 39
- Issue
- 5
- Pages
- 327-346
- ISSN
- 0049-0172 (ISSN-L)
- OpenAlex
- W2004670542
- Cited by
- 291
- References
- 91
- FWCI
- 19.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.